Urinary tract infections in pediatric oncology patients with febrile neutropenia.
10.12701/yujm.2016.33.2.105
- Author:
Kyoo Hyun SUH
1
;
Sun Young PARK
;
Sae Yoon KIM
;
Jae Min LEE
Author Information
1. Department of Pediatrics, College of Medicine, Yeungnam University, Daegu, Korea. mopic@yu.ac.kr
- Publication Type:Original Article
- Keywords:
Urinary tract infections;
Febrile neutropenia;
Pyuria;
Serum β2-microglobulin;
Children
- MeSH:
Academic Medical Centers;
Anti-Bacterial Agents;
Bacterial Infections;
Child;
Diagnosis;
Drug Therapy;
Febrile Neutropenia*;
Fever;
Hematologic Neoplasms;
Humans;
Korea;
Medical Records;
Pediatrics;
Pyuria;
Retrospective Studies;
Urinary Tract Infections*;
Urinary Tract*
- From:Yeungnam University Journal of Medicine
2016;33(2):105-111
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Neutropenic fever is one of the most common and potentially severe complications of chemotherapy in pediatric oncology patients, while urinary tract infection (UTI) is one of the most prevalent bacterial infections in these patients. Therefore, this study was conducted to investigate features of UTI with neutropenic fever in pediatric oncology patients. METHODS: We retrospectively reviewed and analyzed the medical records, laboratory results and image findings of cases of neutropenic fever in the Department of Pediatrics of Yeungnam University Medical Center, South Korea between November 2013 and May 2015. Episodes were divided into two groups, UTI vs. non-UTI group according to the results of urine culture. The results were then compared between groups. The analysis was performed using IBM SPSS 23.0. A p-value <0.05 was considered to indicate a significant difference between groups. RESULTS: Overall, 112 episodes of neutropenic fever were analyzed, among which 22 episodes (19.6%) showed organisms on urine culture and were classified as UTI. The remaining 90 episodes were classified as non-UTI. Only four episodes (18.2%) of the UTI group showed pyuria on urine analysis. In the UTI group, 76.5% were sensitive to the first line antibiotics and showed higher clinical response than the non-UTI group. Among hematologic malignancy patients, the UTI group revealed higher serum β 2-microglobulin levels than the non-UTI group (1.56±0.43 mg/L vs. 1.2±0.43 mg/L, p<0.028). CONCLUSION: UTI in pediatric neutropenic fever responds well to antibiotics. Hematologic malignancy cases with UTI reveal increased serum β2-microglobulin level. These results will be helpful to early phase diagnosis of UTI.
